Covid19
Conditions
Keywords
elderly, COVID, SARS-COV-2, prevalence, dependant care, long-term unit
Brief summary
The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.
Detailed description
Among people exposed to the COVID-19 (SARS-COV-2) pandemic, elderly people are considered as particularly vulnerable, especially those living in nursing homes or hospitalized. Furthermore, facilities / accommodations are registered among the main locations of COVID-19 clusters. These observations have led the French government to establish specific protection measures and survey dependent care facilities for the elderly and long-term care units in the hospital. With these new standards established, a long-term study of all the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.
Interventions
DIAGNOSTIC_TESTSerology testing, RT PCR
Periodic testings and testings with characteristic symptoms occur
Sponsors
Centre Hospitalier Sud Essonne
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* residents of the dependant care facility for the elderly * inpatients of the long-term care unit * from march, 2020 to december, 2021
Exclusion criteria
* opposition to participate in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| General prevalence of COVID-19 | Through the study completion, an average of 12 months | measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of symptomatic residents/inpatients | Through study completion, an average of 12 months | Positive RT-PCR test or serologic test with symptoms |
| Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization | Through study completion, an average of 12 months | Positive RT-PCR test or serologic test and hospitalization |
| Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit | Through study completion, an average of 12 months | Positive RT-PCR test or serologic test and hospitalization in critical care unit |
| Number of asymptomatic residents/inpatients | Through study completion, an average of 12 months | * no RT-PCR test or negative RT-PCR test and positive serologic test, * positive RT PCR and no symptoms. |
| Number of residents/inpatients vaccinated against COVID-19 | Through study completion, an average of 12 months | Positive RT-PCR test or serologic test and vaccinated with any authorized vaccine |
| Influencing factors of the prevalence of COVID-19 among residents/inpatients | Through study completion, an average of 12 months | * age * sex * comorbidities * the context of the infection with COVID-19 * vaccinated or not |
| Number of residents/inpatients infected with COVID-19 and deceased | Through study completion, an average of 12 months | Positive RT-PCR test or serologic test and deceased |
Countries
France
Contacts
Primary ContactShidasp SIAMI, MD, PhD
Backup ContactDelphine LEMAIRE-BRUNEL
Outcome results
None listed